>Although the topic of problem drugs are of great concern globally ,
>there are not many published research papers dealing with
>pharmaceutical regulatory/registration system and policy.
>Many papers came from consumer group trying to state the situation
>of problem drugs and unethical marketing. Some papers also described
>the system used in various countries.
>Some interesting issues raised and/or studied are
>1. The efficiency/ effectiveness of regulatory system and how to assess
>2. The impact of regulatory action/de-registration on availability of
>drug, on rational use, on research and development of drug.
>3. Factors influencing drug regulatory policies
>Does anyone have the information about research in this area of
>to share with. Any comment or suggestion on research issues
>dealing with this area is greatly appreciated.
>Many thanks and best regards,
>HEALTH POLICY UNIT,
>LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE
>LONDON, WC1E 7HT, UK
[This is an interesting topic that is seriously neglected particularly in
evaluating the effects of regulatory changes. There is a recent article in
social science and Medicine by Hilbran Haak and Mariam Claeson on the
banning of anti-diarrheal drugs.
Moderator Richard Laing]>